Abstract:Aims: Several recent reports have shown irisin protects the heart against ischemia/reperfusion injury. However, the effect of irisin on I/R injury in diabetic mice has not been described. The present study was designed to investigate the role of irisin in myocardial ischemia-reperfusion (MI/R) injury in diabetic mice.Methods: A mouse model of diabetes was established by feeding wild type or gene-manipulated adult male mice with a high-fat diet. All the mice received intraperitoneal injection of irisin or PBS. Thirty minutes after injection, mice were subjected to 30 min of myocardial ischemia followed by 3h (for cell apoptosis and protein determination), 24 h (for infarct size and cardiac function).Results: Knock-out of gene FNDC5 augmented MI/R injury in diabetic mice, while irisin treatment attenuated MI/R injury, improved cardiac function, cellular ATP biogenetics, mitochondria potential, and impaired mitochondrion-related cell death. More severely impaired AMPK pathway was observed in diabetic FNDC5-/- mice received MI/R. Knock-out of gene AMPK blocks the beneficial effects of irisin on MI/R injury, cardiac function, cellular ATP biogenetics, mitochondria potential, and mitochondrion-related cell death.Conclusions: Our present study demonstrated that irisin improves the mitochondria function and attenuates MI/R injury in diabetic mice through AMPK pathway.

What problem does this paper attempt to address?

This paper aims to explore the effect of Irisin on myocardial ischemia/reperfusion (MI/R) injury in diabetic mice and its mechanism. Specifically, the researchers hope to determine the following points: 1. **Whether exogenous Irisin supplementation can alleviate myocardial ischemia/reperfusion injury in diabetic mice**: By establishing a diabetic mouse model and treating with Irisin 30 minutes before myocardial ischemia, observe its effect on myocardial infarct size and cardiac function. 2. **Whether Irisin can improve mitochondrial function and inhibit mitochondrial apoptosis under myocardial ischemia/reperfusion injury**: By detecting mitochondrial ATP production, respiratory chain complex activity and the expression of apoptosis - related proteins, evaluate the effect of Irisin on mitochondrial function and apoptosis. 3. **Whether the effect of Irisin depends on the AMPK pathway**: By knocking out the AMPK gene, observe whether the protective effect of Irisin on myocardial ischemia/reperfusion injury still exists in the absence of AMPK. ### Research background - **Diabetes and cardiovascular diseases**: Diabetes is an important risk factor for cardiovascular diseases, and myocardial ischemia/reperfusion injury in diabetic patients is more severe than that in normal animals. - **The role of Irisin**: Irisin is a muscle - secreted factor regulated by PPARγ co - activator 1α (PGC1 - α), which can promote the browning of white adipose tissue and mediate the beneficial effects of exercise, mainly controlling energy, glucose and lipid metabolism. Previous studies have shown that Irisin can reduce oxidative stress and apoptosis. - **AMPK pathway**: AMPK is an energy sensor, which is activated when cell energy is depleted, and restores energy homeostasis by down - regulating ATP - consuming pathways and up - regulating ATP - generating pathways. AMPK plays an important role in the metabolic regulation, vascular protection and cardioprotective effects of Irisin. ### Research methods - **Animal models**: Use high - fat diet - induced type 2 diabetic mouse models, including wild - type (WT), FNDC5 gene - knockout (FNDC5 - / - ) and AMPK gene - knockout (AMPK - / - ) mice. - **Experimental design**: By subjecting the mice to 30 minutes of myocardial ischemia followed by 3 hours or 24 hours of reperfusion, detect cardiomyocyte apoptosis, protein expression, myocardial function and mitochondrial function respectively. - **Irisin treatment**: Treat with Irisin or normal saline (PBS) 30 minutes before myocardial ischemia. ### Main results - **Irisin alleviates myocardial ischemia/reperfusion injury**: Irisin treatment significantly improved cardiac function and reduced myocardial infarct size in diabetic mice. - **Irisin improves mitochondrial function**: Irisin treatment increased mitochondrial ATP production and the activity of respiratory chain complexes. - **Irisin inhibits mitochondrial apoptosis**: Irisin treatment reduced cardiomyocyte apoptosis, as indicated by decreased TUNEL staining and caspase - 3 activity. - **The role of AMPK pathway**: After knocking out the AMPK gene, the protective effect of Irisin was blocked, indicating that the effect of Irisin depends on the AMPK pathway. ### Conclusion This study demonstrates that Irisin alleviates myocardial ischemia/reperfusion injury in diabetic mice through the AMPK pathway, improves mitochondrial function and inhibits mitochondrial apoptosis. These findings provide a theoretical basis for the development of new treatment strategies for diabetic cardiovascular diseases.

Irisin Attenuates Myocardial Ischemia/Reperfusion Injury and Improves Mitochondrial Function Through AMPK Pathway in Diabetic Mice

Irisin Reverses Insulin Resistance in C2C12 Cells Via the P38-Mapk-pgc-1α Pathway.

Antiarrhythmic potentials of irisin in ischemia/reperfusion injury of diabetic rats through modulating mitochondria-endoplasmic reticulum interaction and inhibiting pyroptosis

[Irisin Alleviates Inflammatory Injury in Diabetic Cardiomyopathy by Regulating NF-κB Pathway]

Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy.

Irisin ameliorates high glucose‐induced cardiomyocytes injury via AMPK/mTOR signal pathway

Irisin Plays a Pivotal Role to Protect the Heart Against Ischemia and Reperfusion Injury

Irisin attenuates myocardial ischemia/reperfusion‐induced cardiac dysfunction by regulating ER‐mitochondria interaction through a mitochondrial ubiquitin ligase‐dependent mechanism

Irisin Attenuates Apoptosis Following Ischemia–Reperfusion Injury Through Improved Mitochondria Dynamics and ROS Suppression Mediated Through the PI3K/Akt/mTOR Axis

Irisin Improves Myocardial Performance and Attenuates Insulin Resistance in Spontaneous Mutation (<i>Lepr<SUP>db</SUP></i>) Mice

Irisin Counteracts High Glucose and Fatty Acid-Induced Cytotoxicity by Preserving the AMPK-insulin Receptor Signaling Axis in C2C12 Myoblasts

Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms

Irisin protects cardiomyocytes against hypoxia/reoxygenation injury via attenuating AMPK mediated endoplasmic reticulum stress

Irisin Improves Fatty Acid Oxidation and Glucose Utilization in Type 2 Diabetes by Regulating the AMPK Signaling Pathway.

FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress

Irisin Improves Insulin Resistance by Inhibiting Autophagy Through the PI3K/Akt Pathway in H9c2 Cells.

Irisin Improves Endothelial Function in Type 2 Diabetes Through Reducing Oxidative/nitrative Stresses

Irisin inhibits NLRP3 inflammasome activation in HG/HF incubated cardiac microvascular endothelial cells with H/R injury

Irisin alleviates high glucose-induced hypertrophy in H9c2 cardiomyoblasts by inhibiting endoplasmic reticulum stress

Irisin Deficiency Exacerbates Diet-Induced Insulin Resistance and Cardiac Dysfunction in Type II Diabetes in Mice

Irisin ameliorates myocardial ischemia-reperfusion injury by modulating gut microbiota and intestinal permeability in rats